Total Payments
$16,939
2024 Payments
$1,008
Companies
51
Transactions
492
Medicare Patients
19,016
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$12,699 (75.0%)
Consulting$3,357 (19.8%)
Gifts$507.70 (3.0%)
Education$375.16 (2.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,699 | 483 | 75.0% |
| Consulting Fee | $3,357 | 1 | 19.8% |
| Gift | $507.70 | 1 | 3.0% |
| Education | $375.16 | 7 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $4,998 | 63 | $0 (2024) |
| Rochester Medical Corporation | $1,881 | 38 | $0 (2022) |
| PFIZER INC. | $957.07 | 39 | $0 (2023) |
| Janssen Biotech, Inc. | $916.21 | 34 | $0 (2024) |
| ABBVIE INC. | $802.92 | 47 | $0 (2024) |
| Teleflex LLC | $755.11 | 8 | $0 (2024) |
| NxThera, Inc. | $673.67 | 5 | $0 (2018) |
| Endo Pharmaceuticals Inc. | $648.35 | 47 | $0 (2022) |
| C. R. Bard, Inc. & Subsidiaries | $628.00 | 11 | $0 (2022) |
| Antares Pharma, Inc. | $368.91 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,008 | 46 | Sumitomo Pharma America, Inc. ($209.75) |
| 2023 | $1,471 | 55 | Janssen Biotech, Inc. ($275.01) |
| 2022 | $6,053 | 89 | Astellas Pharma US Inc ($3,622) |
| 2021 | $2,420 | 81 | Rochester Medical Corporation ($853.71) |
| 2020 | $1,068 | 44 | Rochester Medical Corporation ($446.69) |
| 2019 | $1,510 | 58 | Astellas Pharma US Inc ($284.10) |
| 2018 | $891.32 | 46 | Astellas Pharma US Inc ($145.68) |
| 2017 | $2,519 | 73 | NxThera, Inc. ($654.19) |
All Payment Transactions
492 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: HORMONE THERAPY | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.09 | General |
| Category: UROLOGY | ||||||
| 11/25/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Continence Care | ||||||
| 11/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: UROLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: UROLOGY | ||||||
| 10/25/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: UROLOGY | ||||||
| 10/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $3.16 | General |
| Category: UROLOGY | ||||||
| 10/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $5.89 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Immunotherapy | ||||||
| 09/26/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $21.73 | General |
| Category: Prostate cancer | ||||||
| 09/24/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.72 | General |
| Category: UROLOGY | ||||||
| 09/17/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Diagnostic Imaging | ||||||
| 09/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: UROLOGY | ||||||
| 09/13/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/12/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/05/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $3.17 | General |
| Category: UROLOGY | ||||||
| 08/28/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 08/27/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: HORMONE THERAPY | ||||||
| 08/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.17 | General |
| Category: UROLOGY | ||||||
| 08/19/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $24.20 | General |
| Category: Prostate cancer | ||||||
| 08/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 4,738 | 8,627 | $1.1M | $438,239 |
| 2022 | 24 | 4,900 | 9,070 | $1.2M | $486,712 |
| 2021 | 24 | 4,855 | 8,839 | $1.2M | $487,801 |
| 2020 | 26 | 4,523 | 7,850 | $989,600 | $387,451 |
Total Patients
19,016
Total Services
34,386
Medicare Billing
$1.8M
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 829 | 1,893 | $307,995 | $181,117 | 58.8% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Office | 2023 | 84 | 103 | $154,500 | $65,360 | 42.3% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 655 | 919 | $137,850 | $41,549 | 30.1% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2023 | 91 | 91 | $63,700 | $21,381 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 168 | 168 | $37,150 | $20,221 | 54.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 14 | 122 | $61,000 | $15,828 | 25.9% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 90 | 90 | $15,750 | $12,637 | 80.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 79 | 91 | $27,300 | $12,619 | 46.2% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 669 | 1,042 | $156,300 | $10,528 | 6.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 635 | 1,189 | $59,450 | $9,896 | 16.6% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 924 | 2,222 | $44,440 | $8,714 | 19.6% |
| 52214 | Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope | Office | 2023 | 12 | 12 | $18,000 | $7,209 | 40.0% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 26 | 26 | $11,700 | $5,008 | 42.8% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 38 | 38 | $7,600 | $4,231 | 55.7% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 37 | 62 | $7,750 | $3,735 | 48.2% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 48 | 76 | $6,080 | $2,789 | 45.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 23 | $4,080 | $2,748 | 67.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 24 | $4,800 | $2,519 | 52.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 34 | $4,250 | $2,181 | 51.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 26 | $3,125 | $1,814 | 58.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 168 | 211 | $2,110 | $1,748 | 82.8% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 11 | 28 | $3,360 | $1,335 | 39.7% |
| 54235 | Injection procedure to cause erection | Office | 2023 | 11 | 13 | $1,500 | $975.93 | 65.1% |
| 76870 | Ultrasound scan of scrotum | Office | 2023 | 11 | 11 | $1,925 | $920.70 | 47.8% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 15 | 28 | $1,680 | $780.64 | 46.5% |
About Dr. Jeffrey Marks, MD
Dr. Jeffrey Marks, MD is a Urology healthcare provider based in Plantation, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952346918.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Marks, MD has received a total of $16,939 in payments from pharmaceutical and medical device companies, with $1,008 received in 2024. These payments were reported across 492 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($12,699).
As a Medicare-enrolled provider, Marks has provided services to 19,016 Medicare beneficiaries, totaling 34,386 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Plantation, FL
- Active Since 06/16/2006
- Last Updated 11/13/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1952346918
Products in Payments
- Xtandi (Drug) $3,512
- XTANDI (Drug) $1,413
- ERLEADA (Drug) $735.30
- Rezum (Device) $673.67
- XIAFLEX (Biological) $623.61
- UroLift System (Device) $471.22
- Myrbetriq (Drug) $417.52
- GEMTESA (Drug) $380.70
- LUPRON DEPOT (Drug) $362.07
- BMD-BARD Coude Urethral Catheter (Device) $355.36
- MYRBETRIQ (Drug) $335.89
- Urgent PC (Device) $329.63
- XYOSTED (Drug) $296.93
- UROLIFT (Device) $283.89
- PROLARIS (Device) $262.93
- ORGOVYX (Drug) $260.78
- BOTOX (Biological) $249.36
- iTIND System (Device) $245.11
- ELIGARD (Drug) $224.86
- Trelstar (Drug) $213.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Plantation
Dr. Patrick Villicana
Urology — Payments: $20,924
Urology $20,924
Paul Kahn, M.d, M.D
Urology — Payments: $10,670
Urology $10,670
Dr. Christopher Vendryes, Md, Ms, MD, MS
Urology — Payments: $9,503
Urology $9,503
Daniel Ead, Md, MD
Urology — Payments: $5,409
Urology $5,409
Dr. Robert Segaul, M.d, M.D
Urology
Urology
Dr. Jo Kleier, Arnp, ARNP
Urology
Urology